Summary

On January 17, 2024, Belgium inaugurated its new Health Data Agency, a project approved a year earlier. The agency is designed to improve the accessibility and reusability of health data for secondary purposes. This enhancement of data availability will be executed in a manner that ensures both security and adherence to privacy regulations.

Data types Involved

The data encompasses a broad spectrum. Founding members of the ADS (Sciensano, INAMI, SPF Public Health, KCE, AFPMS) have established a framework to map out the extensive data sets targeted, which include health, diseases, medical equipment and products, health determinants, related activities, etc. According to an agency program manager, this data will inherently be public and anonymized.

Structure of the Repository

The platform, as it currently stands, is relatively straightforward. It lists a variety of accessible datasets, while the agency itself does not hold the data. The data is organized using the DCAT_AP format.

Role of the Health Data Agency

The agency acts as an intermediary, facilitating the interaction between those who reuse data and the entities that own it. It offers tools and legal advice to aid in data exchange. Moreover, the agency is responsible for verifying the identity and intentions of data reusers, aligning its operations with the guidelines set forth by the European Health Data Space.

For further details, visit the Agency's website: https://hda.belgium.be/fr.

Seamus Larroque

CDPO / CPIM / ISO 27005 Certified

Home

Discover our latest articles

View All Blog Posts
February 9, 2026
AI
Biotech & Healthtech
Regulations & Guidelines
Healthcare

EU AI Act for Healthcare: What Life Sciences Companies Need to Know before August 2026

EU AI Act 2026 healthcare enforcement requires immediate compliance to avoid penalties.

February 2, 2026
Healthtech
US Privacy Law
USA

Navigating US Regulatory Requirements for AI-Powered Medical Devices: A Comprehensive Guide to FDA, HIPAA, and IRB Compliance

US AI medical device compliance requires navigating FDA, HIPAA, IRBs, and consent waivers strategically.

February 2, 2026
Clinical Trials
Clinical Trial Sponsor
Biotech & Healthtech

VERBIS Registration and Standard Contractual Clauses in Turkey: A Complete Guide for Life Sciences Companies Conducting Clinical Trials

Turkey's VERBIS registration and SCC requirements demand apostilles, tight deadlines, and experienced local guidance.

FAQs

Our frequently questions

No items found.